Literature DB >> 19786942

Comparison of six D-dimer assays for the detection of clinically suspected deep venous thrombosis of the lower extremities.

Klas Boeer1, Robert Siegmund, Dirk Schmidt, Thomas Deufel, Michael Kiehntopf.   

Abstract

Deep venous thrombosis is a common disease that may lead to life-threatening embolism of the lung as a common complication. Therefore, early diagnosis followed by sufficient treatment is necessary to decrease mortality of this disease. D-dimer testing is established as a standard to rule out deep venous thrombosis in selected patient groups. However, there is no standardization among D-dimer assays, and a periodical comparison of assay performance in a select patient group is indispensable. We evaluated six commonly used D-dimer assays for their assay performance in an outpatient cohort with clinically suspected deep venous thrombosis. Although area under the curve for these assays did not differ significantly (0.83-0.88), differences in sensitivity (90-100%) and specificity (10-40%) of the assays were detected. Alternative cut-offs were established, and these cut-offs could enhance assay performance in some cases. This points to the fact that the manufacturers should more regularly review studies on the performance of their respective assays to widen the data basis for their recommended cut-offs and increase assay performance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786942     DOI: 10.1097/MBC.0b013e3283255381

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  The Saudi clinical practice guideline for the diagnosis of the first deep venous thrombosis of the lower extremity.

Authors:  Fahad Al-Hameed; Hasan M Al-Dorzi; Abdulrahman Shamy; Abdulelah Qadi; Ebtisam Bakhsh; Essam Aboelnazar; Mohamad Abdelaal; Tarig Al Khuwaitir; Mohamed S Al-Moamary; Mohamed S Al-Hajjaj; Jan Brozek; Holger Schünemann; Reem Mustafa; Maicon Falavigna
Journal:  Ann Thorac Med       Date:  2015 Jan-Mar       Impact factor: 2.219

2.  Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study.

Authors:  Gilles Pernod; Haifeng Wu; Emmanuel de Maistre; John Lazarchick; Jeannine Kassis; Carlos Aguilar; Pascual M Vera; Gualtiero Palareti; Armando D'Angelo
Journal:  Blood Coagul Fibrinolysis       Date:  2017-04       Impact factor: 1.276

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.